Publication | Open Access
Treatment with abiraterone or enzalutamide does not impair immunological response to COVID-19 vaccination in prostate cancer patients
12
Citations
5
References
2021
Year
VaccinationProstate Cancer PatientsImmunologyTherapeutic VaccineImmunological ResponsePharmacotherapyVaccine EfficacyCovid-19 VaccinationImmunotherapyMedicineVaccine HesitancyCovid-19
| Year | Citations | |
|---|---|---|
Page 1
Page 1